O
STJ

OrbiMed’s St Jude Medical STJ Stock Holding History

OrbiMed’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-173,000
Closed -$11.3M – 148
2014
Q4 		$11.3M Sell
173,000
-850,600
-83% -$54.8M 0.11% 90
2014
Q3 		$61.5M Sell
1,023,600
-640,000
-38% -$41.8M 0.64% 43
2014
Q2 		$115M Buy
1,663,600
+517,000
+45% +$33.5M 1.35% 31
2014
Q1 		$75M Buy
1,146,600
+313,000
+38% +$20.4M 0.92% 34
2013
Q4 		$51.6M Buy
833,600
+713,600
+595% +$41.3M 0.76% 42
2013
Q3 		$6.44M Sell
120,000
-25,000
-17% -$1.29M 0.11% 94
2013
Q2 		$6.62M Buy
+145,000
New +$6.28M 0.14% 91

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

OrbiMed's STJ Position: Q1 2015 in Review

OrbiMed sold out of St Jude Medical (STJ) in Q1 2015, closing a stake of 173,000 shares — an estimated $11.3M sold.

OrbiMed first reported a position in STJ in Q2 2013 and held it in 7 quarters. The position peaked at $115M in Q2 2014. 590 funds tracked by Wall St. Rank hold STJ as of Q1 2015.

  • OrbiMed reported no remaining St Jude Medical position as of Q1 2015 after selling out during the quarter.
  • OrbiMed sold 173,000 St Jude Medical shares in Q1 2015, an estimated $11.3M.
  • OrbiMed first reported a position in St Jude Medical in Q2 2013 and held it in 7 quarters.
  • OrbiMed's St Jude Medical position peaked at $115M in Q2 2014.
  • 590 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2015.

Based on OrbiMed's 13F filing for Q1 2015, filed 15 May 2015.